RICHLAND, Wash. & CORALVILLE, Iowa--(BUSINESS WIRE)--Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, and Viewpoint Molecular Targeting, Inc., a ...
CORALVILLE, IA / ACCESSWIRE / September 29, 2022 / Viewpoint Molecular Targeting, Inc. ("Viewpoint" or the "Company"), a radiopharmaceutical company developing precision lead-212-based α-particle ...
ViewPoint Financial Group, Inc. will be filing with the SEC a registration statement on Form S-4 concerning the merger. The registration statement will include a proxy statement/prospectus, which will ...
“We believe that Perspective Therapeutics truly reflects our potential to transform the field of precision oncology medicine and the outcome of early-stage cancers through the advancement of ...
SBIR Phase II Grants bring the cumulative grant total to approximately $17 million from the National Institutes of Health and National Cancer Institute CORALVILLE, IA / ACCESSWIRE / October 11, 2022 / ...
PLANO, Texas, Oct. 22, 2013 /PRNewswire/ -- ViewPoint Financial Group, Inc. (NASDAQ:VPFG) (the "Company"), the holding company for ViewPoint Bank, N.A., today announced a quarterly cash dividend of $0 ...
ViewPoint Financial Group, Inc. ( VPFG) has announced an ex-dividend date of December 19, 2012 and a cash dividend payment of $0.1 per share scheduled for December 31, 2012. Shareholders who purchased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback